Changes

Jump to navigation Jump to search

Risk

4 bytes added, 14:28, 3 October 2021
no edit summary
[[Lag]]: for diseases such as cancer, there is a minimum latent period (latency) between an exposure and the clinical manifestation of a consequent excess risk of the disease during which no cases attributable to the exposure occur. Therefore, a lag is often introduced in an assessment such that no cases occurring within the minimum latent period following an exposure are included in the assessment. Further, if an exposure is protracted, such as occupational exposures to radiation, exposures are usually lagged so that doses received during the minimum latent period immediately preceding the time at which an assessment is conducted are excluded from the assessment. Examples of minimum latent periods are 2 years for leukaemia, and 5 or 10 years for lung cancer.
[[Lifetime risk]]: the risk over the lifetime of a particular individual of mortality or morbidity from a particular adverse event (e.g. lung cancer) that is related to a given factor (e.g. an exposure to radiation). The lifetime risk is expressed in terms of the length of life expected for a particular individual, such as the risk over the remaining lifetime of a specific disease following a particular dose of radiation at a given age at exposure, assuming an overall lifespan of 90 years.
'''Return to [[ICRP Glossary|Glossary]]'''

Navigation menu